Monday's NASDAQ % Winners: CETV, THRX, QUIK, CYBI

New York, NY - April 3, 2012 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Monday April 02nd. The Nasdaq Composite ended higher by 28.13 (0.91%) to close at 3,119.70.

Central European Media Enterprises Ltd. (NASDAQ:CETV) shares soared 19.58% to close at $8.49 on no official news. Yesterday, the company traded on an above average volume of 1.25 million shares, 3x times its average volume... Central European Media Enterprises Ltd. (CME) is a media and entertainment company operating broadcast, content and new media businesses in Central and Eastern Europe.

Theravance Inc (NASDAQ:THRX) climbed 19.44% on an unusual volume of 2.33 million shares, 5x times its average volume in yesterday's trading session. Theravance and GlaxoSmithKline said that they entered into a stock purchase agreement, under which GSK will acquire 10 million shares of Theravance common stock at a price of $21.2887 per share, for a total investment of $212.887 million. After this purchase GSK's ownership of Theravance would increase from approximately 18.3% to approximately 26.8%. Theravance closed at $23.29 in the last trading session.

QuickLogic Corporation (NASDAQ:QUIK) rose 13.19% to close at $3.09. The shares traded on an above average volume of 709k shares, over 5x times its average volume. The shares of the company have declined over 35% in the last one year. QuickLogic Corporation develops and markets semiconductor solutions.

Cybex International, Inc. (NASDAQ:CYBI) shares climbed 12.65% and closed at $2.85. The 52 week trading range for the company is $0.36 - $3.60. The company has soared over 245% in the last one year. Cybex is a manufacturer of exercise equipments. The Company develops, manufactures and markets strength and cardiovascular fitness equipment products for the commercial and consumer markets.

Horizon Pharma Inc (NASDAQ:HZNP) shares climbed 12.20% and closed at $4.14. The company filed a patent infringement lawsuit in the United States District Court for the District of Delaware against Par Pharmaceutical and related to an Abbreviated New Drug Application that Par filed with the U.S. Food and Drug Administration to market a generic version of DUEXIS(R) tablets.

Get Free investor news and stock alerts at Investorideas.com

Sign Up: http://www.investorideas.com/Resources/Newsletter.asp

Join Investor Ideas Get 13 of the best stock directories online;

Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks Join: http://www.investorideas.com/membership/

About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp

800-665-0411 - Source - www.Investorideas.com